Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort

被引:0
作者
Renée T. Fortner
Danja Sarink
Helena Schock
Theron Johnson
Anne Tjønneland
Anja Olsen
Kim Overvad
Aurélie Affret
Mathilde His
Marie-Christine Boutron-Ruault
Heiner Boeing
Antonia Trichopoulou
Androniki Naska
Philippos Orfanos
Domenico Palli
Sabina Sieri
Amalia Mattiello
Rosario Tumino
Fulvio Ricceri
H. Bas Bueno-de-Mesquita
Petra H. M. Peeters
Carla H. Van Gils
Elisabete Weiderpass
Eiliv Lund
J. Ramón Quirós
Antonio Agudo
Maria-José Sánchez
María-Dolores Chirlaque
Eva Ardanaz
Miren Dorronsoro
Tim Key
Kay-Tee Khaw
Sabina Rinaldi
Laure Dossus
Marc Gunter
Melissa A. Merritt
Elio Riboli
Rudolf Kaaks
机构
[1] German Cancer Research Center (DKFZ),Division of Cancer Epidemiology
[2] Diet,Section for Epidemiology, Department of Public Health
[3] Genes and Environment,Université Paris
[4] Danish Cancer Society Research Center,Saclay
[5] Aarhus University,WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics
[6] Université Paris-Sud,Cancer Risk Factors and Life
[7] UVSQ,Style Epidemiology Unit
[8] CESP,Dipartimento di Medicina Clinica e Chirurgia
[9] INSERM,Cancer Registry and Histopathology Unit
[10] Gustave Roussy,Unit of Cancer Epidemiology, Department of Medical Sciences
[11] Department of Epidemiology,Department of Epidemiology and Biostatistics, School of Public Health
[12] German Institute of Human Nutrition Potsdam-Rehbruecke,Department of Social & Preventive Medicine, Faculty of Medicine
[13] Hellenic Health Foundation,Department of Epidemiology
[14] University of Athens Medical School,MRC
[15] Cancer Research and Prevention Institute – ISPO,PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health
[16] Epidemiology and Prevention Unit,Department of Community Medicine, Faculty of Health Sciences
[17] Department of Preventive & Predictive Medicine Fondazione IRCCS Istituto Nazionale dei Tumori,Department of Medical Epidemiology and Biostatistics
[18] Federico II University,Genetic Epidemiology Group
[19] “Civic - M.p.Arezzo” Hospital,Department of Health and Social Sciences
[20] Unit of Epidemiology,Nuffield Department of Population Health
[21] Regional Health Service ASL TO3,Cancer Epidemiology Unit
[22] University of Turin,undefined
[23] Department for Determinants of Chronic Diseases (DCD),undefined
[24] National Institute for Public Health and the Environment (RIVM),undefined
[25] Imperial College London,undefined
[26] University of Malaya,undefined
[27] Julius Center for Health Sciences and Primary Care,undefined
[28] University Medical Center Utrecht,undefined
[29] Imperial College,undefined
[30] University of Tromsø,undefined
[31] The Arctic University of Norway,undefined
[32] Department of Research,undefined
[33] Cancer Registry of Norway,undefined
[34] Institute of Population-Based Cancer Research,undefined
[35] Karolinska Institutet,undefined
[36] Folkhälsan Research Center,undefined
[37] Public Health Directorate,undefined
[38] Unit of Nutrition and Cancer. Cancer Epidemiology Research Program. Catalan Institute of Oncology-IDIBELL. L’Hospitalet de Llobregat,undefined
[39] Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs. GRANADA. Hospitales Universitarios de Granada/Universidad de Granada,undefined
[40] CIBER de Epidemiología y Salud Pública (CIBERESP),undefined
[41] Department of Epidemiology,undefined
[42] Regional Health Council,undefined
[43] IMIB-Arrixaca,undefined
[44] Universidad de Murcia,undefined
[45] Navarra Public Health Institute,undefined
[46] IdiSNA,undefined
[47] Navarra Institute for Health Research,undefined
[48] Public Health Direction and Biodonostia Research Institute CIBERESP,undefined
[49] Basque Regional Health Department,undefined
[50] University of Oxford,undefined
来源
BMC Medicine | / 15卷
关键词
Breast cancer; Osteoprotegerin; RANK axis; Hormone receptor; Estrogen receptor; Progesterone receptor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 435 条
[1]  
Simonet WS(1997)Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309-19
[2]  
Lacey DL(2003)Osteoclast differentiation and activation Nature 423 337-42
[3]  
Dunstan CR(1999)Breast cancer cells interact with osteoblasts to support osteoclast formation Endocrinology 140 4451-8
[4]  
Kelley M(2000)Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro Biochem Biophys Res Commun 267 632-7
[5]  
Chang MS(2015)Osteoprotegerin in breast cancer: beyond bone remodeling Mol Cancer 14 117-73
[6]  
Lüthy R(2015)Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis BMC Cancer 15 935-77
[7]  
Nguyen HQ(2009)The TRAIL to targeted therapy of breast cancer Adv Cancer Res 103 43-44
[8]  
Wooden S(2012)Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game J Membr Biol 245 763-30
[9]  
Bennett L(2015)Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study BMC Endocr Disord 15 75-91
[10]  
Boone T(2011)Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø study J Thromb Haemost 9 638-35